
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Praesent in nisl sit amet neque accumsan consequat vel et urna. Ut in urna at augue venenatis porta. Nulla hendrerit, risus vel vestibulum feugiat, nibh erat lacinia enim, non euismod magna turpis at arcu. Mauris porta euismod massa, in cursus neque lobortis at.
- Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.
- Suspendisse bibendum vehicula pulvinar. Proin eu felis ut odio viverra dictum.


New COVID-19 Reporting Requirements
UMass Chan has changed its COVID-19 reporting requirements. Effective immediately, UMass Chan employees are no longer required to report positive COVID-19 test results to Employee Health Services.
Read moreLorem Ipsum Dolor
Visit time/date: 11 AM - 4:30 PM on October 21st, 2014
Bluebird Bio, located in Cambridge, MA, is a company focusing on using gene therapy in the treatment of severe genetic and orphan diseases such as beta-thalassemia, sickle cell disease, and various types of cancer. With two clinical stage products, a gene therapy platform widely applicable to a number of diseases, and a focus on providing hope to patients, Bluebird Bio hopes to shift the focus of treatment of these diseases to addressing their underlying causes, rather than through alleviation of symptoms.